📣 Today we announce the appointment of Dr. Christoph Korpus, MBA as Byondis’ new Chief Executive Officer.    Since joining Byondis as Chief Business Officer last year, Christoph has been instrumental in driving our strategic transformation. With more than 15 years of experience spanning oncology R&D, global business development, and strategic partnerships, he brings both deep expertise and a comprehensive understanding of our mission and capabilities.   As CEO, Christoph will guide the advancement of our proprietary antibody-drug conjugate (ADC) technology platforms as we strive to deliver on our mission to enable a new generation of cancer therapeutics for people living with cancer. His cross-discipline expertise and patient-focused vision position Byondis for our next stage of growth.   Read the full announcement here: https://lnkd.in/e4wR4CD4   #ADC #Innovation #CEO #Leadership #Oncology #Byondis #Appointment